NASDAQ · VMD
Healthcare · Medical - Devices
$9.67
Down-$0.28 (-2.81%)
Updated Nov 2, 2026, 3:05 AM
SID Score
7.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · VMD
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
VMD closed at $9.67 after 20 trading sessions, up 4.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $10.00 | $10.025 | $9.6324 | $9.67 | 119.54K |
| Oct 29, 2026 | $10.10 | $10.21 | $9.88 | $9.95 | 227.27K |
| Oct 28, 2026 | $9.66 | $10.01 | $9.66 | $9.99 | 204.78K |
| Oct 27, 2026 | $9.75 | $9.77 | $9.61 | $9.68 | 133.73K |
| Oct 26, 2026 | $9.80 | $9.97 | $9.655 | $9.73 | 156.98K |
| Oct 23, 2026 | $9.91 | $9.99 | $9.76 | $9.80 | 123.15K |
| Oct 22, 2026 | $9.76 | $9.95 | $9.65 | $9.92 | 147K |
| Oct 21, 2026 | $9.80 | $9.86 | $9.65 | $9.75 | 172.49K |
| Oct 20, 2026 | $9.68 | $9.83 | $9.59 | $9.80 | 179.94K |
| Oct 19, 2026 | $9.46 | $9.68 | $9.46 | $9.59 | 185.97K |
| Oct 16, 2026 | $9.76 | $9.83 | $9.42 | $9.48 | 329.43K |
| Oct 15, 2026 | $9.71 | $9.87 | $9.69 | $9.75 | 201.02K |
| Oct 14, 2026 | $9.55 | $9.69 | $9.51 | $9.69 | 220.46K |
| Oct 13, 2026 | $9.63 | $9.67 | $9.52 | $9.61 | 169.62K |
| Oct 12, 2026 | $9.42 | $9.665 | $9.325 | $9.60 | 151.08K |
| Oct 9, 2026 | $9.38 | $9.54 | $9.38 | $9.52 | 152.49K |
| Oct 8, 2026 | $9.39 | $9.60 | $9.26 | $9.41 | 268.64K |
| Oct 7, 2026 | $9.32 | $9.53 | $9.32 | $9.37 | 366.63K |
| Oct 6, 2026 | $9.29 | $9.40 | $9.20 | $9.33 | 260.52K |
| Oct 5, 2026 | $9.15 | $9.30 | $9.09 | $9.24 | 217.81K |
The latest Smart Investors Daily articles mentioning VMD.
Company
Market Activity
Research & News
VMD research
Company profile and research snapshot.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Barrington Research | Outperform | — |
| Aug 6, 2026 | Freedom Broker | Hold | — |
| Nov 3, 2021 | RBC Capital | Outperform | — |
| Mar 5, 2021 | RBC Capital | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 28, 2026
Boston Scientific (BSX) delivered earnings and revenue surprises of 0.00% and +0.68%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Oct 22, 2026
Viemed Healthcare (NASDAQ:VMD) outlined its strategy to expand home-based respiratory care, diversify its revenue mix and maintain organic growth during a company presentation led by Chief Executive Officer Casey Hoyt and Chief Operating Officer Todd Zehnder. Hoyt said the company, which was founde
Yahoo · Oct 22, 2026
LAFAYETTE, LA / ACCESS Newswire / October 22, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Third Quarter 2026 Earnings Conference Call on Thursday, November 5, 2026, at 11:00 a.Interested parties may participate in the call by dialing:877-407-6176 (US Toll-Free)+1 201-689-8451 (International)Live Audio Webcast: https://event.
Yahoo · Oct 7, 2026
Investors need to pay close attention to VMD stock based on the movements in the options market lately.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VMD.
